For example, miR-200c, which is frequently downregulated in TNBC, acts as a tumor suppressor by targeting ZEB1 and ZEB2, key regulators of epithelial-to-mesenchymal transition (EMT) [53]. The gene discussed is ZEB2; the disease is neoplasm.